Evidence map›Paper›PMID 37686948›Full record

ArticleNanomaterials (Basel, Switzerland)2023

A Mid-Infrared Multifunctional Optical Device Based on Fiber Integrated Metasurfaces.

Weikang Yao, Qilin Zhou, Chonglu Jing, Ai Zhou

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Advances in Photonic Metasurfaces and Metastructures.Nanomaterials (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Weikang YaoThe School of Materials Science and Engineering, Wuhan University of Technology, Wuhan 430074, China.
Qilin ZhouThe School of Materials Science and Engineering, Wuhan University of Technology, Wuhan 430074, China.
Chonglu JingThe School of Materials Science and Engineering, Wuhan University of Technology, Wuhan 430074, China.
Ai ZhouNational Engineering Research Center of Fiber Optic Sensing Technology and Networks, Wuhan University of Technology, Wuhan 430070, China.
Wuhan University of Technology · CN

Funding

National Natural Science Foundation of China 62175193
6 · The paper itself

Abstract

A metasurface is a two-dimensional structure with a subwavelength thickness that can be used to control electromagnetic waves. The integration of optical fibers and metasurfaces has received much attention in recent years. This integrated device has high flexibility and versatility. We propose an optical device based on fiber-integrated metasurfaces in the mid-infrared, which uses a hollow core anti-resonant fiber (HC-ARF) to confine light transmission in an air core. The integrated bilayer metasurfaces at the fiber end face can achieve transmissive modulation of the optical field emitted from the HC-ARF, and the Fano resonance excited by the metasurface can also be used to achieve refractive index (RI) sensing with high sensitivity and high figure of merit (FOM) in the mid-infrared band. In addition, we introduce a polydimethylsiloxane (PDMS) layer between the two metasurfaces; thus, we can achieve tunable function through temperature. This provides an integrated fiber multifunctional optical device in the mid-infrared band, which is expected to play an important role in the fields of high-power mid-infrared lasers, mid-infrared laser biomedicine, and gas trace detection.

Indexed as

Fano resonancemetasurfacemid-infraredoptical deviceoptical filterrefractive index sensor

Identifiers

PMID37686948
PMCPMC10489848
OpenAlexW4386250728

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.